XML 13 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Current assets    
Cash and cash equivalents $ 35,284,595 $ 48,251,336
Marketable securities 15,044,750 0
Accounts receivable 15,425,938 8,910,975
Prepaid and other current assets 2,121,145 1,936,842
Total current assets 67,876,428 59,099,153
Other assets    
Property and equipment - net 93,519 171,190
Right of use assets - operating leases 997,777 278,455
Patents and patent applications - net 11,971 13,000
Other non-current assets 0 1,051,234
Total assets 68,979,695 60,613,032
Current liabilities    
Accounts payable and accrued expenses 2,580,904 2,966,479
Accrued salaries and wages 1,347,552 908,516
Royalty payable 3,136,677 1,908,072
Deferred revenue 0 354,756
Operating leases 287,139 282,421
Total current liabilities 7,352,272 6,420,244
Long-term liabilities    
Operating leases - long term 716,343 0
Convertible debt, net of unamortized discount 18,905,723 18,700,546
Total long-term liabilities 19,622,066 18,700,546
Total liabilities 26,974,338 25,120,790
Stockholders' equity    
Common stock; par value $0.001; 200,000,000 shares authorized; 4,618,221 and 4,258,105 shares issued and outstanding at September 30, 2021 and December 31, 2020, respectively 4,618 4,259
Additional paid-in capital 104,460,194 100,203,979
Accumulated other comprehensive loss (26,850) (26,931)
Accumulated deficit (62,432,605) (64,689,065)
Total stockholders' equity 42,005,357 35,492,242
Total liabilities and stockholders' equity $ 68,979,695 $ 60,613,032